Orris
analyse_media
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
I now have excellent textbook content. Let me compile the complete, detailed answers to all questions shown in the image.

Drugs Acting on the Autonomic Nervous System - Complete Answers

This page is from a pharmacology textbook covering anticholinergic/antimuscarinic drugs. Here are detailed answers to all questions:

SECTION 2 Questions

Question 1 (Bronchodilator that blocks muscarinic receptors in airways)

a. Drug and mechanism: The bronchodilator that blocks muscarinic receptors in the airways is Ipratropium bromide (a quaternary ammonium antimuscarinic). It blocks M3 muscarinic receptors on bronchial smooth muscle, preventing acetylcholine-mediated bronchoconstriction, thereby causing bronchodilation. It also reduces respiratory secretions.
b. Why more useful in COPD than bronchial asthma: Ipratropium is more useful in COPD because in COPD the dominant bronchoconstrictive tone is parasympathetic/cholinergic (vagal), whereas asthma is primarily an inflammatory, IgE-mediated, and beta-adrenergic disorder. Beta-2 agonists work better in asthma since the bronchospasm is more reversible and histamine/leukotriene-driven.
c. Two long-acting muscarinic antagonists (LAMAs) in COPD:
  • Tiotropium (once daily, inhaled)
  • Umeclidinium (once daily, inhaled); others include aclidinium and glycopyrrolate
d. Important adverse effects: Dry mouth (xerostomia), urinary retention, constipation, blurred vision, tachycardia, and worsening of narrow-angle glaucoma if mist reaches eyes.

Question 2 (5-year-old with fever, dilated pupils, flushed dry skin, hallucinations, difficulty urinating - ingestion of berries)

a. Most likely diagnosis: Anticholinergic toxidrome - most likely Belladonna/Deadly Nightshade (Atropa belladonna) poisoning or Datura (Jimson weed) ingestion. These plants contain atropine, hyoscyamine, and scopolamine alkaloids.
b. Why is this plant drug: These plants contain tropane alkaloids (atropine = dl-hyoscyamine, scopolamine) that are competitive muscarinic receptor antagonists.
c. How to confirm diagnosis: Clinical diagnosis based on the classic anticholinergic toxidrome ("hot as a hare, dry as a bone, red as a beet, blind as a bat, mad as a hatter, full as a flask"). Confirm with:
  • Physostigmine challenge (reversal of symptoms confirms anticholinergic cause)
  • Urine/blood toxicology screen
d. Observed clinical features: Hyperthermia, mydriasis (dilated pupils), flushed/red dry skin (anhidrosis), tachycardia, urinary retention, hallucinations, dry mouth, ileus, delirium.
e. Mechanism behind features: Blockade of M3 receptors on:
  • Sweat glands → anhidrosis → hyperthermia + dry flushed skin
  • Iris sphincter → mydriasis
  • Bladder detrusor → urinary retention
  • SA node blockade → tachycardia
  • CNS muscarinic blockade → hallucinations/delirium
  • Salivary glands → dry mouth
f. Pharmacological treatment: Physostigmine (a tertiary amine anticholinesterase that crosses the BBB), which reverses both central and peripheral anticholinergic effects. Dose: 1-2 mg IV slowly. Supportive care: cooling, benzodiazepines for agitation, catheterization for urinary retention.

Question 3 (10-year-old boy brought to eye OPD - ophthalmologist prescribes mydriasis and cycloplegia, child develops photophobia and difficulty in near vision after instillation)

a. Drug used: Atropine eye drops (1%) for refraction testing in children. Atropine is the preferred cycloplegic in children because:
  • Maximum cycloplegia achieved (paralysis of ciliary muscle)
  • Duration suits children's stronger accommodation
b. Mechanism of action in the eye: Atropine blocks M3 muscarinic receptors in:
  • Sphincter pupillae → mydriasis (pupil dilation)
  • Ciliary muscle → cycloplegia (loss of accommodation for near vision)
c. Why photophobia develops: Mydriasis prevents the pupil from constricting in bright light, so more light enters the eye → photophobia.
d. Why difficulty in near vision: Paralysis of the ciliary muscle prevents the lens from increasing curvature (accommodation), so the child cannot focus on near objects.
e. Two shorter-acting cycloplegic/mydriatic drugs:
  • Tropicamide (shortest acting, 4-6 hours) - preferred for routine refraction in adults
  • Cyclopentolate (6-24 hours) - used in children
f. Why atropine less preferred in children for routine refraction testing: Atropine's effects last 7-14 days, which is inconveniently long for routine use. Shorter-acting agents like cyclopentolate or tropicamide are preferred for routine testing.
g. Therapeutic uses of atropine in ophthalmology:
  • Refraction testing in children (maximum cycloplegia needed)
  • Treatment of anterior uveitis/iridocyclitis (prevents posterior synechiae)
  • Penalization therapy in amblyopia ("lazy eye" treatment)

Question 4 (28-year-old woman planning a long sea voyage - prescribes drug patch applied behind the ear 4 hours before travel)

a. Drug used: Scopolamine (Hyoscine) transdermal patch
b. Central effects of this drug with atropine: Scopolamine penetrates the BBB more effectively than atropine. Central effects:
  • Antiemetic (motion sickness prevention) - primary use
  • Sedation and drowsiness
  • Amnesia (used in pre-anesthesia)
  • Euphoria (abuse potential)
  • At higher doses: delirium, hallucinations, excitement
c. Two other anticholinergics used for:
  • Motion sickness: Dimenhydrinate (antihistamine with anticholinergic activity), Promethazine
  • GI colic/antispasmodic: Dicyclomine, Hyoscine butylbromide (Buscopan)
d. Common adverse effects: Dry mouth, blurred vision (cycloplegia), urinary retention, constipation, drowsiness, dizziness, skin irritation at patch site, tachycardia.

REASONING TYPE QUESTIONS (Give Reason Why)

1. Atropine produces tachycardia but may cause initial bradycardia on parenteral injection: At low/small doses, atropine preferentially blocks presynaptic M1 receptors on parasympathetic nerve endings, which normally inhibit ACh release. Blocking these allows MORE ACh to be released, increasing vagal tone transiently → bradycardia. At higher therapeutic doses, atropine blocks postsynaptic M2 receptors at the SA node, removing vagal inhibition → tachycardia.
2. Atropine is contraindicated in patients with narrow-angle glaucoma: Atropine causes mydriasis (M3 blockade in iris sphincter). In narrow-angle (angle-closure) glaucoma, the dilated pupil pushes the peripheral iris against the trabecular meshwork, blocking the angle of the anterior chamber. This impairs aqueous humor drainage and raises intraocular pressure dangerously, potentially causing acute angle-closure crisis.
3. Ipratropium is more effective in COPD than bronchial asthma (Page 146): In COPD, the dominant mechanism of airflow limitation involves enhanced cholinergic/vagal tone causing bronchoconstriction. Ipratropium blocks this effectively. In asthma, the primary pathology is allergic inflammation, mast cell degranulation, and leukotriene release - mechanisms not blocked by anticholinergics. Beta-2 agonists are more effective in asthma.
4. Tiotropium is preferred over ipratropium in long-term control of COPD: Tiotropium is a once-daily LAMA with high selectivity for M3 receptors and slow dissociation (prolonged bronchodilation for 24 hours). Ipratropium requires 3-4 times daily dosing due to its shorter duration. Tiotropium also has slightly greater bronchodilator effect and better adherence.
5. Glycopyrrolate is preferred as a pre-anesthetic medication instead of atropine: Glycopyrrolate is a quaternary ammonium compound that does NOT cross the blood-brain barrier. Therefore it:
  • Reduces secretions without causing CNS effects (sedation, confusion)
  • Does not cause tachycardia as strongly
  • Longer duration than atropine
  • Fewer CNS side effects in the perioperative period Atropine crosses the BBB and can cause post-operative confusion/delirium.
6. Tropicamide is preferred over atropine for routine refraction testing in adults: Tropicamide has a much shorter duration of action (4-6 hours vs 7-14 days for atropine). Patients return to normal vision the same day. Atropine's prolonged effects are unnecessary for routine adult refraction and impair daily function.
7. Atropine is used as an antidote in organophosphate poisoning: Organophosphates inhibit acetylcholinesterase, causing accumulation of ACh at all muscarinic and nicotinic synapses. This produces a cholinergic crisis (miosis, bradycardia, bronchospasm, increased secretions, diarrhea). Atropine competitively blocks muscarinic receptors, reversing the muscarinic effects (bronchospasm, bradycardia, secretions). Doses up to 20-50 mg may be needed. [Pralidoxime is given concurrently to regenerate cholinesterase and address nicotinic effects.]
8. Anticholinergic side effects are most pronounced when combined with tricyclic antidepressants or antihistamines: TCAs and many antihistamines have significant intrinsic antimuscarinic activity. When combined with atropine or other anticholinergics, the anticholinergic effects are additive/synergistic, causing severe dry mouth, urinary retention, constipation, blurred vision, confusion, and tachycardia.
9. Darifenacin and solifenacin are more suitable than atropine for overactive bladder: These are selective M3 receptor antagonists with bladder selectivity (low CNS penetration, quaternary-like selectivity). Atropine is non-selective and causes systemic side effects (dry mouth, blurred vision, tachycardia, CNS effects). Darifenacin/solifenacin provide bladder-specific action with fewer systemic side effects.
10. Atropine reduces gastric secretion but is less effective and less preferred: While atropine does reduce gastric secretion via M1/M3 blockade, the doses needed for adequate acid suppression cause intolerable systemic anticholinergic side effects. Selective H2 blockers (ranitidine) and proton pump inhibitors (omeprazole) are far more effective and specific with fewer side effects.
11. Atropine is contraindicated in elderly patients with prostatic hypertrophy: Atropine blocks M3 receptors on the detrusor muscle of the bladder, reducing its ability to contract. In a patient with prostatic hypertrophy, where there is already partial bladder outflow obstruction, atropine further impairs bladder emptying and can precipitate acute urinary retention.
12. Physostigmine is preferred over neostigmine in atropine/belladonna poisoning: Physostigmine is a tertiary amine anticholinesterase that crosses the blood-brain barrier. This allows it to reverse central anticholinergic effects (hallucinations, delirium, coma) as well as peripheral effects. Neostigmine is a quaternary amine that cannot cross the BBB, so it only reverses peripheral muscarinic effects (bradycardia, secretions) but leaves the CNS symptoms untreated.

MULTIPLE CHOICE QUESTIONS (1 Mark)

1. The drug of choice for motion sickness prophylaxis in highly susceptible individuals: B. Hyoscine (Scopolamine)
  • Rationale: Scopolamine transdermal patch is the most effective prophylactic agent for motion sickness. It has superior CNS penetration and longer duration (72 hours) compared to other options.
  • Atropine (A) - not preferred for motion sickness
  • Dicyclomine (C) - antispasmodic, not for motion sickness
  • Glycopyrrolate (D) - quaternary, does not cross BBB, ineffective for motion sickness
Sources: Lippincott Illustrated Reviews: Pharmacology; Katzung's Basic and Clinical Pharmacology, 16th Edition; Morgan & Mikhail's Clinical Anesthesiology, 7th Edition
This is a shared conversation. Sign in to Orris to start your own chat.